Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2002-08-02
2008-08-12
Foley, Shanon A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S234100, C424S184100, C530S350000, C530S300000, C536S023700, C435S320100, C435S252100, C435S199000, C435S069700
Reexamination Certificate
active
07410647
ABSTRACT:
A method for the identification of antigenic polypeptides, typically opsonic antigens, expressed by pathogenic microbes; vaccines comprising said antigens; and therapeutic antibodies directed to said antigenic polypeptides.
REFERENCES:
patent: 5543323 (1996-08-01), Ridley et al.
patent: 6086896 (2000-07-01), Sparling et al.
patent: WO 99/50418 (1999-10-01), None
patent: WO 02/094868 (2002-11-01), None
patent: WO 02/102829 (2002-12-01), None
US 6,159,469, 12/2000, Choi et al. (withdrawn)
Rudinger et al, in “Peptide Hormones”, edited by Parsons, J.A., University Park Press, Jun. 1976.
Burgess et al., The Journal of Cell Biology, 111:2129 2138, 1990.
Lazar et al., Molecular and Cellular Biology, 8(3): 1247 1252, 1988.
Jobling et al. (Mol. Microbiol. 1991, 5(7): 1755 67.
Coleman et al. (Research in Immunology, 1994; 145(1): 33-36.
Abaza et al. (Journal of Protein Chemistry, vol. 11, No. 5, 1992, pp. 433-444.
Roitt et al, 1998, Immunology, 4th ed, Mosby, London p. 7.7-7.8.
Holmes (Exp. Opin.Invest. Drugs, 2001, 10(3):511-519.
Herbert et al. (The Dictionary of Immunology, Academic Press, 4th edition, 1995, p. 58).
Greenspan et al., Nature Biotechnology 7:936-937 (1999).
Barash et al.,Staphylococcus aureus polynucleotides and sequences(Mar. 1999); Accession No. XP002250642.
Kuroda et al.,Whole genome sequencing of meticillin-resistant Staphylococcus aureus(Jun. 2001); Accession No. XP002250643.
Sahin et al.,Serological identification of human tumor antigens, Current Opinion in Immunology, vol. 9, No. 5, pp. 709-716 (Oct. 1997).
Wood et al.,Identification of antigenic sites on staphylococcal enterotoxin B and toxoid, FEMS Immunology and Medicinal Microbiology, vol. 17, pp. 1-10 (1997).
Masignani et al.,Staphylococcus aureus proteins and nucleic acids(Feb. 2003); Accession No. XP002250644.
Masignani,Staphylococcus aureus proteins and nucleic acids(Feb. 2003); Accession No. XP002250645.
Masignani,Staphylococcus aureus proteins and nucleic acids(Feb. 2003); Accession No. XP002250646.
Masignani,Staphylococcus aureus proteins and nucleic acids(Feb. 2003); Accession No. XP002250647.
Kuroda et al., “Whole genome sequencing of meticillin-resistantStaphylococcus aureus,” Lancet. Apr. 21, 2001;357(9264):1225-40.
Rahman, A. et al., “Gamma-Hemolysin Genes in the Same Family withLuk-Fandluk SGenes in Methillicin ResistantStaphylococcus aureus,” Biosci. Biotech. Biohem., 57(7):1234-36 (1993).
Foster, Simon, “Molecular Characterization and Functional Analysis of the Major Autolysin ofStaphylococcus aureus8325/4,”J. of Bacteriology, 177(19):5723-5725 (1995).
Brummel Kristy
Clarke Simon
Foster Simon
McDowell Philip
Mond James
Baskar Padma v
Biosynexus Incorporated
Casimir Jones S.C.
Foley Shanon A.
University of Sheffield
LandOfFree
Antigenic polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4004691